Brokerages expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to post $0.62 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Sabra Health Care REIT’s earnings. The lowest EPS estimate is $0.60 and the highest is $0.64. Sabra Health Care REIT posted earnings per share of $0.60 during the same quarter last year, which would suggest a positive year over year growth rate of 3.3%. The business is expected to announce its next quarterly earnings report on Wednesday, November 7th.
According to Zacks, analysts expect that Sabra Health Care REIT will report full-year earnings of $2.47 per share for the current year, with EPS estimates ranging from $2.39 to $2.51. For the next year, analysts forecast that the business will post earnings of $2.50 per share, with EPS estimates ranging from $2.31 to $2.62. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Sabra Health Care REIT.
Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, August 8th. The real estate investment trust reported $1.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.75. Sabra Health Care REIT had a return on equity of 11.21% and a net margin of 62.60%. The business had revenue of $166.31 million during the quarter, compared to analyst estimates of $166.62 million.
A number of equities analysts have weighed in on the company. ValuEngine downgraded Sabra Health Care REIT from a “sell” rating to a “strong sell” rating in a research report on Thursday, June 21st. BidaskClub raised Sabra Health Care REIT from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 23rd. Zacks Investment Research raised Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Wednesday, July 11th. Jefferies Financial Group reaffirmed a “$21.91” rating and set a $22.00 price target on shares of Sabra Health Care REIT in a research report on Wednesday, July 18th. Finally, Mizuho reaffirmed a “buy” rating and set a $26.00 price target on shares of Sabra Health Care REIT in a research report on Monday, August 13th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $22.73.
A number of large investors have recently added to or reduced their stakes in SBRA. Capital Fund Management S.A. bought a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth approximately $2,169,000. OppenheimerFunds Inc. raised its stake in shares of Sabra Health Care REIT by 112.0% during the 2nd quarter. OppenheimerFunds Inc. now owns 68,422 shares of the real estate investment trust’s stock worth $1,487,000 after purchasing an additional 36,144 shares in the last quarter. Price Capital Management Inc. bought a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth approximately $756,000. Bank of New York Mellon Corp raised its stake in shares of Sabra Health Care REIT by 0.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 2,663,709 shares of the real estate investment trust’s stock worth $57,881,000 after purchasing an additional 12,607 shares in the last quarter. Finally, Standard Life Aberdeen plc bought a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth approximately $507,000. 90.40% of the stock is owned by hedge funds and other institutional investors.
Shares of SBRA opened at $21.19 on Wednesday. The company has a debt-to-equity ratio of 1.00, a current ratio of 3.16 and a quick ratio of 3.16. Sabra Health Care REIT has a 52-week low of $15.77 and a 52-week high of $23.83. The company has a market capitalization of $4.12 billion, a P/E ratio of 8.72, a price-to-earnings-growth ratio of 2.74 and a beta of 0.62.
About Sabra Health Care REIT
As of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.
Further Reading: Leveraged Buyout (LBO) Explained
Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.